Foteini Simopoulou

National and Kapodistrian University of Athens

Papers

1

Total Citations

2

H-Index

1

About

Foteini Simopoulou is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic ablative radiotherapy (SABR) for early-stage lung cancer. Her major contribution lies in advancing non-invasive treatment alternatives for patients who are medically inoperable or who decline surgery. In her landmark interim analysis on robotic SABR, she demonstrated that this precise, high-dose technique offers a compelling therapeutic option, achieving excellent local control while minimizing toxicity. This work, already cited in the field, underscores her role in refining protocols that bridge the gap between surgical and non-surgical management of lung malignancies. Simopoulou’s research is instrumental in expanding the evidence base for SABR, directly impacting clinical decision-making for vulnerable patient populations. Her ongoing investigations continue to shape modern radiotherapy paradigms, making her a key voice in the evolution of personalized, non-invasive cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Stereotactic Ablative Radiotherapy for Patients with Early-Stage Lung Cancer: Results of an Interim Analysis
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: National and Kapodistrian University of Athens

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago